Monitoring Extended Half‐Life Factor VIII and IX Concentrates: Performance in Routine Clotting‐and Thrombin Generation Assays

Documenti analoghi

• Thrombin Generation in Pediatric Haemophilia A Patients on Extended Half‐Life FVIII versus Non‐FVIII Therapies
  di: Jessica Garcia, et al.
  Pubblicazione: (2026)
• Utilising Thrombin Generation Assay to Guide Co‐Administration of Factor Therapies With Fitusiran
  di: Yesim Dargaud, et al.
  Pubblicazione: (2025)
• Monitoring of Nonacog Beta Pegol: One‐Stage Clotting Assay With Kaolin Reagent as a Practical Alternative to Chromogenic Methods
  di: Marie Prudková, et al.
  Pubblicazione: (2025)
• Orthopaedic Surgery Outcomes in Patients With Haemophilia A or B Treated With Extended Half‐Life Recombinant Factor VIII and IX Fc Fusion Proteins: A Multicentre Prospective Study
  di: Luigi Piero Solimeno, et al.
  Pubblicazione: (2025)
• Evaluation of One‐Stage Assays for the Monitoring of Recombinant Human Factor IX Padua Activity After Etranacogene Dezaparvovec Gene Therapy
  di: Jan Astermark, et al.
  Pubblicazione: (2025)